BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30464600)

  • 1. Overexpression of lncRNA
    Yang L; Zhou JD; Zhang TJ; Ma JC; Xiao GF; Chen Q; Deng ZQ; Lin J; Qian J; Yao DM
    Cancer Manag Res; 2018; 10():4999-5007. PubMed ID: 30464600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
    Huang HW; Xie H; Ma X; Zhao F; Gao Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PANDAR overexpression serves as a poor prognostic biomarker in oral squamous cell carcinoma.
    Huang Z; Sang T; Zheng Y; Wu J
    Int J Clin Exp Pathol; 2018; 11(5):2728-2734. PubMed ID: 31938389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
    Ma P; Xu T; Huang M; Shu Y
    Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
    Tan Z; Zhu K; Yin Y; Luo Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
    Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
    Luo W; Yu H; Zou X; Ni X; Wei J
    Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
    Li J; Sun CK
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia].
    Zhou YL; Xu ZJ; Zhou JD; Zhang TJ; Yao DM; Ma JC; Lin J; Qian J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1436-1449. PubMed ID: 34627422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma.
    Xu Y; Jiang X; Cui Y
    Onco Targets Ther; 2017; 10():2873-2883. PubMed ID: 28652769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
    Wang Y; Li Y; Song HQ; Sun GW
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High bone marrow
    Zhou JD; Ma JC; Zhang TJ; Li XX; Zhang W; Wu DH; Wen XM; Xu ZJ; Lin J; Qian J
    Oncotarget; 2017 Nov; 8(54):91979-91989. PubMed ID: 29190891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.
    Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H
    Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia.
    Hola MAM; Ali MAM; ElNahass Y; Salem TAE; Mohamed MR
    Int J Lab Hematol; 2021 Aug; 43(4):732-742. PubMed ID: 34129278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.